<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Science, technology as economic drivers</title>
		<description>Discuss Science, technology as economic drivers</description>
		<link>http://www.oregonbusiness.com/linda/8554-science-technology-as-economic-drivers</link>
		<lastBuildDate>Sat, 18 May 2013 11:03:52 +0000</lastBuildDate>
		<generator>JComments</generator>
		<atom:link href="http://www.oregonbusiness.com/component/jcomments/feed/com_content/8554" rel="self" type="application/rss+xml" />
		<item>
			<title>Chief Executive Officer</title>
			<link>http://www.oregonbusiness.com/linda/8554-science-technology-as-economic-drivers#comment-3059</link>
			<description><![CDATA[Where the NIH/SBIR system truly breaks down is in the most critical area of all, funding the commercializati on process. The truth is the Phase II fast-track grants assist a company in building the prototype, sourcing a manufacturer and allows them to enter--but possibly--not complete the FDA clearance process. Since the intent of the SBIR grants is to assist a small business in bringing a medical product to market that benefits patient care, there needs to be more monies set aside for the Phase IIB bridge grant area where the complete focus is on FDA clearance, commercializati on and market introduction, which actually can be the the most expensive part of the product development. Unfortunately, too many scientists are used in the review process for Phase IIB commercializati on grants versus favoring reviewers who are business people and entrepreneurs who understand how products come to market and are launched. If the NIH, or other SBIR granting agencies, can fix the Phase IIB commercializati on process, there will be more new products coming to market, more new high paying jobs created, and more new viable, successful and profitable ventures. The NIH has told grantees it is going through a "re-engineering process" design to enhance efficiency, speed approval and provide grants that support successful ventures. Since it is an old and established bureaucracy, run mostly by scientists and academics, it is yet to be known if they can accomplish this lofty goal.]]></description>
			<dc:creator>Guest</dc:creator>
			<pubDate>Fri, 16 Nov 2012 18:03:29 +0000</pubDate>
			<guid>http://www.oregonbusiness.com/linda/8554-science-technology-as-economic-drivers#comment-3059</guid>
		</item>
	</channel>
</rss>
